Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
2017 1
2019 3
2021 3
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of exogenous beta-hydroxybutyrate for preventive treatment in episodic migraine: A single-centred, randomised, placebo-controlled, double-blind crossover trial.
Putananickal N, Gross EC, Orsini AL, Schmidt S, Hafner P, Gocheva V, Nagy S, Henzi BC, Rubino D, Vogt DR, Cichon S, Sandor P, Fischer D. Putananickal N, et al. Among authors: gross ec. Cephalalgia. 2022 Apr;42(4-5):302-311. doi: 10.1177/03331024211043792. Epub 2021 Sep 20. Cephalalgia. 2022. PMID: 34541914 Clinical Trial.
Need for new review of article on ketogenic dietary regimes for cancer patients.
Klement RJ, Feinman RD, Gross EC, Champ CE, D'Agostino DP, Fine EJ, Kämmerer U, Poff A, Rho JM, Seyfried TN, Scheck AC. Klement RJ, et al. Among authors: gross ec. Med Oncol. 2017 Jun;34(6):108. doi: 10.1007/s12032-017-0968-4. Epub 2017 Apr 27. Med Oncol. 2017. PMID: 28452037 No abstract available.
Metabolic markers of short and long-term exogenous DL-beta-hydroxybutyrate supplementation in episodic migraine patients: an exploratory analysis of a randomized-controlled-trial.
Putananickal N, Gross EC, Orsini AL, Schmidt S, Hafner P, Gocheva V, Nagy S, Henzi BC, Rubino D, Schädelin S, Sandor P, Fischer D. Putananickal N, et al. Among authors: gross ec. Front Pharmacol. 2023 May 4;14:1172483. doi: 10.3389/fphar.2023.1172483. eCollection 2023. Front Pharmacol. 2023. PMID: 37214431 Free PMC article.
Problems associated with a highly artificial ketogenic diet: Letter to the Editor Re: van der Louw EJTM, Olieman JF, van den Bemt PMLA, et al. 'Ketogenic diet treatment as adjuvant to standard treatment of glioblastoma multiforme: a feasibility and safety study'.
Klement RJ, Sweeney RA, Gross EC, Champ CE. Klement RJ, et al. Among authors: gross ec. Ther Adv Med Oncol. 2019 Oct 14;11:1758835919879268. doi: 10.1177/1758835919879268. eCollection 2019. Ther Adv Med Oncol. 2019. PMID: 31662797 Free PMC article. No abstract available.